Therefore A1874 acts via both BRD4-dependent and BRD4-independent (p53 stabilization and ROS production) mechanisms, providing an explanation for its superior anticancer activity against colon cancer cells. The gene discussed is BRD4; the disease is malignant colon neoplasm.